~~<i id='1232CE1B39'><strike id='1232CE1B39'><tt id='1232CE1B39'><pre id='1232CE1B39'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：leisure time 2025-09-28 02:26:58 - browse：429

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Quicker fix for pulse oximeters urged during FDA public meeting

focus

leisure time

knowledge

explore

knowledge

CommitteeRankingRepublicanBillCassidy(La.)andChairmanBernieSanders(I-Vt.)ChipSomodevilla/GettyImages

WSS

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Vertex non

Some dementia cases could be undiagnosed liver disease

Mom launches Girl Scout troop for LGBTQ youth in Texas

Cognito secures funding to test medical device for Alzheimer's

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

focus

explore

focus

Affirmative action in medical school literally saved lives

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Virginia high school admissions case could be legal follow

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

New air purifier tech could be key to improving indoor air quality

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

United colonoscopy coverage change 'may cost lives,' doctors say

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

State Dept. review finds Biden bears some blame for Afghanistan failures

Mom launches Girl Scout troop for LGBTQ youth in Texas

leisure time

Biden administration plans revamp of organ transplant system

Bispecific antibodies are next new thing in cancer immunotherapy

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

The real point of Kenneth Smith’s execution by nitrogen gas

Living organ donors deserve priority status for transplants

Biden administration opens offers in Medicare drug price negotiations

knowledge

explore

knowledge

knowledge